BackNanoViricides Overview

NanoViricides Current Assets

Latest current assets for NNVC: $3.4T.

Get informed when a big investor buys or sells

+ Follow
Current Assets
$3377.91B
123855162.30% YoYΔ $3377.91B vs prior year quarter

Peer average

Loading

NanoViricides Current Assets History

Loading

NanoViricides vs. peers: Current Assets Comparison

Loading

NanoViricides Current Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

NanoViricides (NNVC) FAQ

NanoViricides (NNVC) currently reports a current assets of $3.4T as of March 2026. That compares with $2.7M in the prior-year period — up 123855162.3% year over year. Use the charts on this page to explore NanoViricides's current assets history and peer comparisons.

NanoViricides's current assets increased from $2.7M to $3.4T — a 123855162.3% year-over-year increase (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

NanoViricides reported $3.4T in current assets as of March 2026. That compares with $2.7M in the prior-year period — up 123855162.3% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current assets of $3.4T, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for NanoViricides, and consider following NNVC for alerts when major investors trade the stock.

NanoViricides is classified in the Healthcare sector. On current assets, it currently shows $3.4T. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing NNVC with unrelated industries.